Data as of Aug 29
| -0.01 / -0.29%|
The 3 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a +187.36% increase from the last price of 3.48.
The current consensus among 3 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.